Editing Scrambled Genes in Human Stem Cells May Help Realize the Promise of Stem Cell-Gene Therapy Using mutated versions of the lamin A gene as an example to demonstrate the versatility of their virus-based approach, researchers successfully edited a diseased gene in patient-specific induced pluripotent stem cells as well as adult stem cells. [Press release from EurekAlert! discussing online prepublication in Cell Stem Cell]
Possible New Target for Sarcoma Treatment and Prevention A team of researchers compared normal human mesenchymal stem cells to human sarcoma cells and found that the sarcoma cells displayed hyperactive signaling along the Wnt pathway. [Press release from ScienceDaily discussing online prepublication in Cancer Cell]
Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCs Scientists show that helper-dependent adenoviral vectors provide a highly efficient and safe method for correcting mutations in large genomic regions in human induced pluripotent stem cells (iPSCs) and can also be effective in adult human mesenchymal stem cells. [Cell Stem Cell]
Ministry of Health Approves BrainStorm’s NurOwn™ for the First Clinical Trial of Adult Stem Cell Therapy for ALS BrainStorm Inc., a leading developer of adult stem cell technologies and therapeutics, and Hadasit, the technology transfer company of the Hadassah Medical Organization, announced that Israel’s Ministry of Health has approved the Phase I/II clinical trial of NurOwn™, BrainStorm’s autologous stem cell therapy for people with amyotrophic lateral sclerosis. [Brainstorm Inc. Press Release]
Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.